Unknown

Dataset Information

Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of Leishmania infection.


ABSTRACT:

Introduction

Leishmaniasis is a parasitic disease that affects more than 1 million people worldwide annually, predominantly in resource-limited settings. The challenge in compound development is to exhibit potent activity against the intracellular stage of the parasite (the stage present in the mammalian host) without harming the infected host cells. We have identified a compound series (pyrazolopyrrolidinones) active against the intracellular parasites of Leishmania donovani and L. major; the causative agents of visceral and cutaneous leishmaniasis in the Old World, respectively.

Methods

In this study, we performed medicinal chemistry on a newly discovered antileishmanial chemotype, with over 100 analogs tested. Studies included assessments of antileishmanial

SUBMITTER: Kavouris JA 

PROVIDER: S-EPMC9937549 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature